You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nivolumab plus Ipilimumab

Showing 1 - 25 of 1,594
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

Not yet recruiting
  • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
  • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
  • +2 more
  • (no location specified)
Aug 16, 2022

Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Tampa, Florida
  • +1 more
Nov 11, 2022

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

Active, not recruiting
  • Melanoma
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
  • Toulouse, France
    Institut Claudius Regaud IUCT-ONCOPOLE
Nov 18, 2022

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Athens, Greece
      Local Institution - 0001
    Oct 26, 2022

    MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

    Completed
    Has Results
    • MGMT-unmethylated Glioblastoma (GBM)
    • GBM
    • New York, New York
      New York University School of Medicine
    Jun 30, 2022

    Renal Cell Carcinoma, Melanoma, Solid Tumor Trial in Pittsburgh (Phase Ib ARRY-614 + nivolumab, Phase Ib ARRY-614 +

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Phase Ib ARRY-614 + nivolumab
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2022

    Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

    Recruiting
    • Breast Neoplasm Female
    • +3 more
    • New York, New York
    • +1 more
    Dec 21, 2022

    Non Small Cell Lung Cancer Trial in Toronto (diagnostic test, drug, combination product)

    Recruiting
    • Non Small Cell Lung Cancer
    • cfDNA blood test
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    May 9, 2022

    Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)

    Completed
    • Metastatic Hormone-Sensitive Prostate Cancer
    • PROSTVAC-V
    • +9 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 3, 2022

    Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

    Not yet recruiting
    • Metastatic Nasopharyngeal Carcinoma
    • +2 more
    • Nivolumab
    • +5 more
    • (no location specified)
    Aug 21, 2023

    Lung Cancer, SCLC Trial in United States (Nivolumab, Plinabulin, Ipilimumab)

    Recruiting
    • Lung Cancer
    • SCLC
    • Duarte, California
    • +7 more
    Jan 18, 2023

    Larynx, Lip, Oral Cavity and Pharynx Trial in Philadelphia (Nivolumab, Ipilimumab, Simultaneous-Integrated Boost

    Completed
    • Larynx
    • Lip, Oral Cavity and Pharynx
    • Nivolumab
    • +3 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Nov 16, 2022

    Relapsed DLBCL, Refractory DLBCL Trial in New York (Ipilimumab, Nivolumab)

    Completed
    • Relapsed Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Apr 4, 2022

    Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

    Recruiting
    • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
    • Herlev, Denmark
      Herlev & Gentofte University Hospital, Denmark
    Oct 13, 2022

    Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)

    Recruiting
    • Lung Cancer Metastatic
    • Durham, North Carolina
      Duke Univ. Medical Center
    May 16, 2022

    Malignant Glioma Trial in Tampa, Columbus (Hypofractionated Stereotactic Irradiation, Nivolumab, Bevacizumab)

    Active, not recruiting
    • Malignant Glioma
    • Hypofractionated Stereotactic Irradiation
    • +3 more
    • Tampa, Florida
    • +1 more
    Mar 23, 2022

    Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

    Not yet recruiting
    • Advanced Soft-tissue Sarcoma
    • (no location specified)
    May 26, 2023

    Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

    Not yet recruiting
    • Metastatic Extraskeletal Myxoid Chondrosarcoma
    • +3 more
    • Biopsy
    • +6 more
    • (no location specified)
    Apr 25, 2023

    Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

    Not yet recruiting
    • Pleural Biphasic Mesothelioma
    • Pleural Sarcomatoid Mesothelioma
    • Nivolumab
    • +5 more
    • (no location specified)
    Dec 9, 2022

    Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in Duarte

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Biospecimen Collection
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Sep 19, 2023

    Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

    Not yet recruiting
    • Metastatic Nasopharyngeal Carcinoma
    • +2 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Jun 13, 2023

    Urothelial Cancer Trial in Spain (Nivolumab, Ipilimumab)

    Recruiting
    • Urothelial Cancer
    • Huelva, Andalucia, Spain
    • +11 more
    Dec 1, 2022

    Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

    Recruiting
    • Colon Carcinoma
    • Amsterdam, Netherlands
    • +5 more
    Jan 23, 2023